Fibrinopeptide A
-
Subject Areas on Research
- Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995.
- Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
- Effects of local heparin administration on coronary thrombin activity during percutaneous transluminal coronary angioplasty.
- Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
- Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
- Role of fibrinopeptide B in early atherosclerotic lesion formation.
- Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
- The effect of hypercholesterolemia on early atherosclerotic lesions initiated by fibrinopeptide B.
- Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.